Physician profile
Manoj Sharma
NPI 1033105242
$10,463.23
in general payments reported to CMS, 2019-2025
40 companies · $1,708 in 2025
The $1,708 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,249 · 2020: $420 · 2021: $602 · 2022: $1,430 · 2023: $3,062 · 2024: $1,992 · 2025: $1,708.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,931 · Travel and Lodging: $2,832.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,930.96 |
| Travel and Lodging | $2,831.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $5,022.52 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Pascal |
| Medtronic, INC. | $992.58 | 2021-2025 | Corevalve Evolut R |
| Abiomed | $760.42 | 2021-2025 | Impella |
| Boston Scientific Corporation | $665.70 | 2019-2024 | Rotapro, Watchman Flx |
| Novartis Pharmaceuticals Corporation | $413.82 | 2019-2025 | |
| Abbott Laboratories | $313.23 | 2019-2024 | Optis |
| Shockwave Medical, INC | $254.93 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Janssen Pharmaceuticals, INC | $217.71 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $197.87 | 2019-2025 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $179.71 | 2019-2025 | Lifevest |
| Pfizer INC. | $174.74 | 2019-2025 | |
| Recor Medical INC | $139.01 | 2025 | Paradise Ultrasound Renal Denervation System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $114.63 | 2019-2020 | |
| Philips North America LLC | $110.09 | 2025 | Coronary Other, Igt Devices Undivided |
| Sanofi-Aventis U.S. LLC | $105.58 | 2019-2022 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manoj Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.